Defining the questions to be asked in severe asthma trials
Data from the COMSA working group
Recent publication
Prim. Assoc. Prof. PD Dr Thomas Eiwegger, Head of the Department of Pediatrics and Adolescent Medicine at KL, writes in his editorial together with Sarah A. Bendien from the Haga Teaching Hospital in the Netherlands about the challenge of making successful asthma therapy with biologics measurable. The Core Outcome Measures sets for paediatric and adult Severe Asthma (COSMA) group address standardized options in an issue of the European Respiratory Journal, making it important for advancing treatment approaches for asthma with biologics.
Original paper: Eiwegger T, Bendien SA. Defining the questions to be asked in severe asthma trials: data from the COMSA working group. European Respiratory Journal. 2023 Apr 3;61(4). doi: 10.1183/13993003.02058-2022
Prim. Assoc. Prof. Univ.-Doz. Dr. Thomas Eiwegger
Scientific Working Group Clinical Immunology, Division of Paediatrics (University Hospital St. Pölten)
